Wang et al., 2023 - Google Patents
Targeting intracellular and extracellular receptors with nano-to-macroscale biomaterials to activate immune cellsWang et al., 2023
- Document ID
- 9367403525706196472
- Author
- Wang B
- Cui H
- Kiessling F
- Lammers T
- Baumjohann D
- Shi Y
- Publication year
- Publication venue
- Journal of Controlled Release
External Links
Snippet
Activation of immune cells is an essential process in innate and adaptive immunity. A high number of immune cell activation pathways have been discovered, which are stimulated via various intra-and extracellular receptors. Small-molecule and macromolecular agonists …
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wang et al. | Targeting intracellular and extracellular receptors with nano-to-macroscale biomaterials to activate immune cells | |
Lei et al. | Hydrogel-guided strategies to stimulate an effective immune response for vaccine-based cancer immunotherapy | |
Lee et al. | Vaccine adjuvants to engage the cross-presentation pathway | |
Kowalczyk et al. | Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity | |
Sun et al. | Injectable hydrogels coencapsulating granulocyte-macrophage colony-stimulating factor and ovalbumin nanoparticles to enhance antigen uptake efficiency | |
Baker et al. | The role of FcRn in antigen presentation | |
JP2023160828A (en) | Particles encapsulating fusion proteins containing linked epitopes | |
Kohno et al. | Photoreceptor proteins initiate microglial activation via Toll-like receptor 4 in retinal degeneration mediated by all-trans-retinal | |
Tullett et al. | Harnessing human cross-presenting CLEC9A+ XCR1+ dendritic cells for immunotherapy | |
EA202091816A1 (en) | METHOD OF DRUG DELIVERY TO MUSCLE | |
JP2019515044A (en) | DNA monoclonal antibodies that target checkpoint molecules | |
MX2019007714A (en) | Article for treating diabetic peripheral neuropathy. | |
Dumont et al. | Controlled release strategies for modulating immune responses to promote tissue regeneration | |
Kim et al. | Combination of sunitinib and PD-L1 blockade enhances anticancer efficacy of TLR7/8 agonist-based nanovaccine | |
MX2013014461A (en) | Sustained release formulations for delivery of proteins to the eye and methods of preparing same. | |
WO2017161360A4 (en) | Multimodal vector for dendritic cell infection | |
WO2017044803A8 (en) | Expression vector delivery system and use thereof for inducing an immune response | |
US20220347308A1 (en) | Methods and means for inducing an immune response | |
Liu et al. | Hyaluronidase-functionalized silica nanocarrier for enhanced chemo-immunotherapy through inducing immunogenic cell death | |
Prakash | mRNA-based nanomedicine: A new strategy for treating infectious diseases and beyond | |
MX2017003377A (en) | Codon-optimized recombinant plasmid, method of stimulating peripheral nerve regeneration, and method of treating nerve damage in humans. | |
WO2020176900A1 (en) | Galectin-1/ galectin-3 chimeras and multivalent proteins | |
CA3212593A1 (en) | Dna-encoded bispecific antibodies targeting il13r?2 and methods of use in cancer therapeutics | |
Zafar et al. | Innovative approaches in immunomodulation for cell-based therapies. Agrobiological Records 19: 59-70 | |
Dalal et al. | Functionalized Poly (ethylene Glycol) Diacrylate Scaffolds for In Situ Immunomodulation of Dendritic Cells Targeting Melanoma Tumor |